entertainment -WSS

entertainment

author：Wikipedia 2025-10-02 19:39:12 - browse：64

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

A couple billion here, a couple billion there, and pretty soon Eli Lilly hopes it will be talking about real money.

Eli Lilly agreed to purchase Point Biopharma Tuesday morning for $1.4 billion, a 90% premium, adding to its pipeline of cancer drugs. Point is developing cancer drugs that deliver a focused dose of radiation to tumor cells. Data for its lead medicine, for prostate cancer, are expected in the fourth quarter. It is also developing a drug for neuroendocrine tumors.

Point operates a 180,000-square-foot radiopharmaceutical manufacturing facility in Indianapolis, and a radiopharmaceutical research and development center in Toronto.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Doctors are clamoring for more clarity on Paxlovid prescribing

focus

WSS

STAT Summit: Michael J. Fox on progress in Parkinson's research

Doctors push to include dialysis machines in emergency stockpile

FDA gives detailed accounting of AI

Many breast cancer patients receive more radiation than needed

Impact of Dobbs ruling felt at reproductive medicine meeting

Pharmacists can make shortage drugs, but at what cost?

hotspot

entertainment

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

CEOs share strategies for surviving biotech slump

State Dept. review finds Biden bears some blame for Afghanistan failures

First Opinion Podcast: Long Covid needs a new approach

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

STAT Summit: Michael J. Fox on progress in Parkinson's research

Virginia high school admissions case could be legal follow

NIH confirmation hearing shows politicization of research

Continuity nursing helped my family in our darkest PICU moments

How climate

knowledge

Senate committee scrutinizes Medicare Advantage brokers

NFL doctors' conflicts of interest could endanger players, report says

STAT Summit: Biotech founders on deal

Feed a cold, starve a fever? Here’s what science says

Paxlovid rebound happens. Why and to whom are still a mystery

2023 STAT Wunderkinds: get to know the winners

Wikipedia

focus

focus

knowledge